Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Andersen

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Breast Cancer Research and Treatment|January 1, 1986
Steroid hormone receptors as prognostic indicators in primary breast cancerS M Thorpe, C Rose, B B Rasmussen, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]P Dombernowsky, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]H S Thomsen, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]C K Axelsson, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|October 23, 1995
[Menstrual cycle and surgery of breast cancer. Point of time for the surgery of primary breast cancer in connection with menstrual cycle is without prognostic significance]N T Kroman, A D Højgaard, K W Andersen, et al.
Annals of Surgery|July 1, 1981
Selection of high risk groups among prognostically favorable patients with breast cancerJ A Andersen, K Fischermann, K Hou-Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative GroupG van Tienhoven, A C Voogd, J L Peterse, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Breast Cancer Research and Treatment|January 1, 1986
Steroid hormone receptors as prognostic indicators in primary breast cancerS M Thorpe, C Rose, B B Rasmussen, et al.
Ugeskrift for Laeger|August 12, 1991
[Adjuvant chemotherapy in premenopausal and menopausal high-risk patients with breast cancer. 4. Results of the DBCG (Danish Breast Cancer Cooperative Group) 77B study]P Dombernowsky, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]H S Thomsen, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|August 12, 1991
[Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)]C K Axelsson, J A Andersen, K W Andersen, et al.
Ugeskrift for Laeger|October 23, 1995
[Menstrual cycle and surgery of breast cancer. Point of time for the surgery of primary breast cancer in connection with menstrual cycle is without prognostic significance]N T Kroman, A D Højgaard, K W Andersen, et al.
Annals of Surgery|July 1, 1981
Selection of high risk groups among prognostically favorable patients with breast cancerJ A Andersen, K Fischermann, K Hou-Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative GroupG van Tienhoven, A C Voogd, J L Peterse, et al.
Pageof 6